NCT04129697
Unknown
Not Applicable
Intratympanic Dexamethasone or Methylprednisolone for Sudden Hearing Loss as a Salvage Treatment: a Randomized, Double-blind, Multi-center Study
Second Affiliated Hospital, School of Medicine, Zhejiang University0 sites30 target enrollmentJanuary 1, 2020
InterventionsDexamethasone or Methylprednisolone
Overview
- Phase
- Not Applicable
- Intervention
- Dexamethasone or Methylprednisolone
- Conditions
- Dexamethasone or Methylprednisolone; Sudden Hearing Loss; Intratympanic Steroid
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Enrollment
- 30
- Primary Endpoint
- hearing
- Last Updated
- 6 years ago
Overview
Brief Summary
For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. An randomized, double-blind, multi-center study is designed to find the difference between Dexamethasone or Methylprednisolone.
Investigators
Eligibility Criteria
Inclusion Criteria
- •sudden hearing loss and initial treatment is not effective
Exclusion Criteria
- •the patients refused intratympanic steroids treatment.
Arms & Interventions
Dexamethasone
Intervention: Dexamethasone or Methylprednisolone
Methylprednisolone
Intervention: Dexamethasone or Methylprednisolone
Outcomes
Primary Outcomes
hearing
Time Frame: six month
the hearing level after treatment
Similar Trials
Completed
Phase 1
Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of TinnitusTinnitusNCT03265197saad elzayat44
Completed
Phase 3
A Comparison of Hearing Level between Before and After Intratympanic Dexamethasone Injection in Patient with Sudden Sensorineural Hearing Loss after Failure of Oral Prednisolone TherapyIntratympanic Dexamethasone Injection in Patient with Sudden Sensorineural Hearing Loss after Failure of Oral Prednisolone TherapyIdiopathic sudden sensorineural hearing lossIntratympanic dexamethasone injectionineffective oral prednisoloneTCTR20220128003Chaophrayayommarat Hospital Ethical Committee40
Withdrawn
Phase 2
High Dose Oral Steroids in Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss (SSNHL)NCT03255473University of Colorado, Denver4
Completed
Not Applicable
Dexamethasone for the Prevention of Recurrent Laryngeal Nerve PalsyBenign Neoplasm of Thyroid GlandMalignant Neoplasm of ThyroidNCT01690806Università degli Studi dell'Aquila328
Withdrawn
Not Applicable
Dexamethasone in Preventing Hearing Loss in Patients Receiving CisplatinMalignant NeoplasmOtotoxicityNCT02382068Aaron Moberly